EGFR-mutated tumors showed a significantly higher necrosis/contrast enhancing ratio (p = 0.05) and a significantly lower contrast enhancing/tumor bulk ratio (p = 0.008) (Fig. 5b). Here, EGFR is linked to neoplasm.